Biogen Idec Canada gets approval from Health Canada for new MS drug
Biogen Idec Canada has received approval from Health Canada for a first-line oral treatment for adults with relapsing forms of MS
Tag: biotechnology
National Pharmaceutical Congress will focus on problems in marketing
Next week’s National Pharmaceutical Congress will address problems in pharma marketing
Karen K. Ho 